Your browser doesn't support javascript.
loading
Integrative overview of IFITMs family based on Bioinformatics analysis.
Liu, Pengchao; Zhang, Yongtao; Zhang, Shanshan; Peng, Chuanming; Yang, Wei; Li, Xianxian; Zhang, Chao; Li, Mian; Han, Jinxiang; Lu, Yanqin.
Afiliación
  • Liu P; Department of Endocrinology, The First Affiliated Hospital of Shandong First Medical University, Ji'nan, Shandong, China.
  • Zhang Y; Key Laboratory for Biotech-Drugs of National Health Commission, Key Laboratory for Rare & Uncommon Diseases of Shandong Province, Biomedical Sciences College & Shandong Medicinal Biotechnology Centre, Shandong First Medical University & Shandong Academy of Medical Sciences, Ji'nan, Shand
  • Zhang S; Department of Endocrinology, The First Affiliated Hospital of Shandong First Medical University, Ji'nan, Shandong, China.
  • Peng C; Key Laboratory for Biotech-Drugs of National Health Commission, Key Laboratory for Rare & Uncommon Diseases of Shandong Province, Biomedical Sciences College & Shandong Medicinal Biotechnology Centre, Shandong First Medical University & Shandong Academy of Medical Sciences, Ji'nan, Shand
  • Yang W; Department of Endocrinology, The First Affiliated Hospital of Shandong First Medical University, Ji'nan, Shandong, China.
  • Li X; Key Laboratory for Biotech-Drugs of National Health Commission, Key Laboratory for Rare & Uncommon Diseases of Shandong Province, Biomedical Sciences College & Shandong Medicinal Biotechnology Centre, Shandong First Medical University & Shandong Academy of Medical Sciences, Ji'nan, Shand
  • Zhang C; Department of Endocrinology, The First Affiliated Hospital of Shandong First Medical University, Ji'nan, Shandong, China.
  • Li M; Key Laboratory for Biotech-Drugs of National Health Commission, Key Laboratory for Rare & Uncommon Diseases of Shandong Province, Biomedical Sciences College & Shandong Medicinal Biotechnology Centre, Shandong First Medical University & Shandong Academy of Medical Sciences, Ji'nan, Shand
  • Han J; Department of Endocrinology, The First Affiliated Hospital of Shandong First Medical University, Ji'nan, Shandong, China.
  • Lu Y; Key Laboratory for Biotech-Drugs of National Health Commission, Key Laboratory for Rare & Uncommon Diseases of Shandong Province, Biomedical Sciences College & Shandong Medicinal Biotechnology Centre, Shandong First Medical University & Shandong Academy of Medical Sciences, Ji'nan, Shand
Intractable Rare Dis Res ; 10(3): 165-172, 2021 Aug.
Article en En | MEDLINE | ID: mdl-34466338
ABSTRACT
Human interferon-induced transmembrane proteins (IFITMs) family is a multi-functional biomacromolecule family playing a critical role in various physiological processes, such as, antiviral immunity, tumor suppression, and bone formation. Although there are many studies proving that a subset of tumors strongly links to the changes of IFITMs, the link between different IFITMs mutant types and diverse tumors has not been studied thoroughly. To investigate the law of expression among IFITMs internal members and the linking of IFITMs mutant types and cancers, online databases were used to pool together relevant data for bioinformatics analysis. Here, we summarize mutations, expression, and functions of human IFITMs, analyze diverse expression levels of IFITMs in physiological and pathological tissues, predict protein-protein interaction (PPI) networks, and target miRNAs and relevant signaling pathways of IFITMs. The results show that IFITM1, IFITM2, and IFITM3 have similar motif pattern constructions and physiological functions, while IFITM5 and IFITM10 show far diversity from them. Particularly, IFITM1-3, in conjunction with interacting proteins, is strongly related to development and overall survival rates of a portion of cancers, including renal cancer and uveal melanoma (UVM). This trait may make IFITM1-3 become a prognostic marker of cancers. Meanwhile, hsa_circ_0116375 has been found as the common circRNA for IFITM2, IFITM3, IFITM5, and IFITM10.
Palabras clave

Texto completo: 1 Colección: 01-internacional Idioma: En Revista: Intractable Rare Dis Res Año: 2021 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Idioma: En Revista: Intractable Rare Dis Res Año: 2021 Tipo del documento: Article País de afiliación: China